Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism by Zimmerman, Kirsten & Caldwell, Nikki
James Madison University 
JMU Scholarly Commons 
Physician Assistant Capstones The Graduate School 
Spring 5-4-2017 
Age-adjusted vs conventional D-dimer thresholds in the diagnosis 
of venous thromboembolism 
Kirsten Zimmerman 
James Madison University 
Nikki Caldwell 
James Madison University 
Follow this and additional works at: https://commons.lib.jmu.edu/pacapstones 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Caldwell PN, Zimmerman KZ. Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous 
thromboembolism. JMU Scholarly Commons Physician Assistant Capstones. 
http://commons.lib.jmu.edu/pacapstones/20. Published May 16, 2017. 
This Presentation is brought to you for free and open access by the The Graduate School at JMU Scholarly 
Commons. It has been accepted for inclusion in Physician Assistant Capstones by an authorized administrator of 
JMU Scholarly Commons. For more information, please contact dc_admin@jmu.edu. 
 1 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Age-Adjusted vs Conventional D-dimer Thresholds in the Diagnosis of Venous 
Thromboembolism 
Nikki Caldwell and Kirsten Zimmerman 
James Madison University 
December 2, 2016 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 2 
Abstract 
 
Context: D-dimer measurements are vital in the diagnosis and exclusion of venous 
thromboembolism (VTE). D-dimer levels increase with age, causing many older individuals to 
be subject to unnecessary imaging in the diagnostic process. The implementation of an age-
adjusted D-dimer may help to improve specificity of the test, therefore, preventing further 
imaging.  
Objective: To assess whether the application of age-adjusted cutoff values (age x 10 µg/L) 
compared to a conventional cutoff value (500 µg/L) improves diagnostic accuracy of the D-
dimer test in older individuals (>50 years) with suspected venous thromboembolism (VTE) 
without compromising safety.  
Methods:  A PubMed search was conducted utilizing the term “age-adjusted D-dimer” with the 
addition of the MeSH terms “Sensitivity and Specificity” and limitation to English studies from 
the past five years. A review was performed on three studies that compared the efficacy of age-
adjusted D-dimer to conventional cutoff values in patients > 50 years old.   
Results: Scouten et al. found that the specificity of the conventional cutoff decreased with age, 
from 66.8% in patients less than 50 to 14.7% in those aged >80.  Specificity was increased to 
35.2% with the use of age-adjusted cutoffs. Sensitivities remained above 97% with the age-
adjusted cutoff in all categories. Sharp et al. found that the age-adjusted D-dimer threshold was 
more specific (64%) versus the conventional cutoff off 500 µg/L (54%), but less sensitive (93% 
versus 98%). Righini et al. found that the sensitivity of the D-dimer test did not change with the 
application of an age-adjusted threshold, but the specificity increased from 30.8% to 43.5% 
versus the conventional cutoff. 
Conclusion: The use of age-adjusted values for the D-dimer test improves specificity without 
compromising sensitivity, effectively improving clinical usefulness of the D-dimer test and 
reducing imaging among patients >50 years with suspected venous thromboembolism (VTE). 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations and Acronyms 
Venous thromboembolism – VTE 
Pulmonary embolism – PE 
Deep vein thrombosis – DVT 
Emergency department – ED  
Computed tomography – CT  
Contrast induced nephropathy – CIN 
Computed tomography pulmonary 
angiography – CTPA 
Confidence interval – CI 
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Introduction 
 
Venous thromboembolism (VTE) is the leading cause of morbidity and mortality in 
hospitalized patients,1 prompting research on the most effective diagnostic technique. D-dimer 
concentrations are commonly measured in the workup for the patient with non-high clinical 
probability of VTE2, whereas patients with high probability would be candidates for immediate 
diagnostic imaging. Non-high clinical probability is typically determined with the use of Wells 
score for deep vein thrombosis (DVT) and pulmonary embolism (PE) and with the use of the 
revised Geneva score for PE. These clinical probability rules use items such as age, past history 
of DVT and PE, and clinical signs and symptoms to assign a low, intermediate or high 
probability to patients with suspected VTE.1  
High levels of D-dimer, one of the byproducts of fibrinolysis, indicate acute clotting and 
fibrinolytic processes occurring in the body.3 The D-dimer test’s high sensitivity makes it one of 
the preferred first line tests for excluding VTE in patients with symptoms of a PE or DVT and a 
non-high clinical probability.2 However, specificity for the D-dimer test is low,4 subjecting many 
patients with D-dimer values above the cutoff value to unnecessary imaging. Many factors alter 
the specificity of the D-dimer test, such as duration of symptoms, extent of thrombosis, 
anticoagulant therapy, inflammatory diseases, cancer, pregnancy, and previous VTE.1 In 
addition, D-dimer naturally increases with age. As a result, many older patients (age >50 years) 
have a D-dimer concentration higher than the conventional cutoff value (500 µg/L) in the 
absence of thromboembolism. This further reduces the specificity of the test significantly and 
leads to unnecessary imaging in a large portion of the elderly population presenting with VTE 
symptoms and a non-high clinical probability. Patients are subjected to increased risks from 
radiation and contrast agents and the burden of increased cost of care.5 To increase the 
specificity, it has been suggested that the D-dimer cutoff be increased for patients over the age of 
50. Therefore, the use of an age-adjusted D-dimer cutoff (age x 10) is gaining popularity. To 
date, no consensus has been made as to whether this method is safe and effective for the elderly 
population. This study researches the efficacy of using an age-adjusted D-dimer cutoff to exclude 
VTE in patients >50 years of age with a non-high clinical probability.2,5  
  
  
Case  
Mr. R.D. is a 67-year-old male with no significant past medical history that presents to the clinic 
complaining of right lower extremity swelling. His D-dimer is 640 µg/L. Does he need further 
testing for a DVT at this time?  
  
PICO 
Population: Older patients (>50 years) with suspected venous thromboembolism (VTE) 
Intervention: Age-adjusted D-dimer cutoff (age x 10 µg/L) 
Control: Conventional D-dimer cutoff (500 µg/L) 
Outcome: Increased accuracy in the exclusion of VTE using a D-dimer assay in older patients 
(>50 years) 
 
Clinical Question 
In patients over 50 years of age, does an age-adjusted D-dimer cutoff as compared to the 
conventional cutoff value increase the accuracy in the exclusion of VTE? 
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Methods 
 
An initial PubMed search was conducted 
in September 2016 using the search term “age 
adjusted D-dimer” to retrieve 47 articles. This 
search was narrowed further by limiting the 
search to “English,” limiting the publication date 
to the last five years, and implementing MeSH 
terms “Sensitivity and Specificity” to yield 10 
articles. A meta-analysis and systematic review 
article was selected as the primary article. Two 
articles were excluded, as they were included in 
the previously selected meta-analysis. Five more 
articles were excluded on the basis of low 
statistical power and because many of them 
included extraneous outcomes that were 
unrelated to the clinical question. Thus, three 
articles remained, including the primary meta-
analysis, a prospective study, and a retrospective 
cohort study with high statistical power. This 
selection process is summarized in Figure 1.    
 Statistical methods used in this review 
include sensitivity, specificity, positive 
predictive value, negative predictive value, and 
negative likelihood ratio of both the conventional and age-adjusted thresholds. Sensitivity and 
specificity were provided in study 1, but the data used to calculate these values were not 
supplied, therefore, positive and negative predictive values were unable to be calculated. All of 
the statistical calculations for study 2 used in the review were provided by the original study. 
Study 3 did not provide sensitivity and specificity; however, these values were calculated by the 
authors of this review using original data from the study. Sensitivity and specificity were then 
used to calculate negative likelihood ratios, which were applied to a nomogram to find post-test 
probabilities. Pre-test probability was calculated based on the case for this review using the 
Wells criteria for DVT. 
 
 
Results 
Study 1:  
Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients 
with suspected venous thromboembolism: systematic review and meta-analysis. Schouten et al.2 
 
Objective 
 The objective of this study was to determine the accuracy of age-adjusted D-dimer cutoff 
values compared to the conventional cutoff value in identifying VTE in patients > 50 years old.  
 
 
 
Figure 1. PRISMA flow chart 
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Study Design 
This is a systematic review and meta-analysis comparing 13 cohorts from five separate 
studies identified by searching Medline and Embase. Eligible studies consisted of primary 
research articles that compared consecutive patients with a clinical suspicion of VTE, performed 
D-dimer testing using both the age-adjusted and conventional cutoff values, and confirmed 
diagnosis with reference testing. Studies containing patients at a high risk for thrombosis, 
defined as perioperative patients or patients with previous thrombosis, cancer, or coagulation 
disorders were excluded. The revised tool for quality assessment of diagnostic accuracy studies 
(QUADAS-2) was used to evaluate the quality of the chosen studies.  
The studies included patients in the emergency department (ED), one primary care office, 
outpatient clinics, and inpatients with symptoms and signs of VTE. Risk was determined using 
either a revised Geneva score or the Wells criteria in all but one study. Patients considered to 
have a non-high clinical probability had a revised Geneva score of < 10 or a Wells score of < 4 
for PE, and a Wells score of < 2 or < 1 for DVT. One study used a clinical probability of <80% 
as determined by the treating physician as their risk stratification method. 12 of the 13 studies 
used three-month event-free follow-up to confirm results. One study used diagnostic imaging.  
 2x2 tables were created using the true and false positive and negative rates derived by the 
reference tests. They were categorized into different age groups (< 50, 51-60, 61-70, 71-80, 
>80). The tables were used to determine prevalence, sensitivity, and specificity of VTE in each 
age category. A random effects bivariate regression model was used for the meta-analysis. This 
statistical model analyzes relationships between variables which have been derived from 
different populations. In this case, the true and false positive and negative rates from the 13 
separate cohorts and five different age categories were included in the analysis.  
The authors also constructed hypothetical cohorts with 1,000 patients per age category and D-
dimer cutoff level. Hypothetical cases of VTE were determined by multiplying 1,000 by the 
average prevalence of VTE for each age category as found in the studies used for the meta-
analysis. True positives and negatives were calculated for each age group, as well as the effects 
of prevalence on each one. True positives were calculated by multiplying the number of 
hypothetical cases by the estimated sensitivity of the D-dimer test for the particular age category. 
True negatives were calculated by multiplying the number of hypothetical non-cases by the 
estimated specificity. Results were also multiplied by the minimum and maximum prevalence of 
VTE in each age category. 
 
Results 
The meta-analysis showed that the use of an age-adjusted D-dimer cutoff significantly 
(P<0.005) increased specificity in age categories >50 years of age compared to the conventional 
cutoff. Specificity still decreased as age increased, but at a much less pronounced rate. Using the 
conventional method, specificity decreased remarkably as age increased, dropping from 66.8% in 
patients less than age 50 to 14.7% in patients over the age of 80. Using age-adjusted values, 
specificity decreased to 35.2% in patients aged greater than 80. Overall sensitivity and specificity 
were also calculated for the entire cohort aged greater than 50. Sensitivity was 99.3% (95% 
confidence interval 98.4% to 99.7%) for the conventional cutoff and 97.8% (95.9% to 98.9%) for 
the age-adjusted cutoff. Specificity was 36.1% (30.8% to 41.7%) for conventional cutoff and 
48.8% (42.9% to 54.7%) for age-adjusted.  
The hypothetical cohorts were used to determine how many patients would have avoided 
imaging, correctly or incorrectly, by the use of age-adjusted D-dimer. As shown in Table 1, 
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using age-adjusted cutoffs greatly increased the number of patients that avoided unnecessary 
testing, while only missing a minute number of cases. The number of missed cases would be 
comparable to the failure rate of the conventional cutoff value for patients <50 years, a rate of 3 
per 1,000. The age-adjusted cutoff also increased the positive predictive value in patients over 80 
to 21.2%, almost increasing it to that of patients younger than 50, 29.1%.  
 
Table 1. Number of imaging studies avoided and VTE cases missed with age-adjusted 
cutoffs 
Age (years) Unnecessary imaging studies 
avoided 
VTE cases missed 
51-60 40 1 
61-70 85 2 
71-80 155 3 
>80 175 4 
 
 
Study 2: 
An Age-Adjusted D-dimer Threshold for Emergency Department Patients with Suspected 
Pulmonary Embolus: Accuracy and Clinical Implication. Sharp et al.5 
 
Objective  
To determine the accuracy of an age-adjusted D-dimer threshold to detect PE in ED 
patients over 50 years old.  
 
Study Design  
This was a retrospective cohort study of suspected pulmonary embolism ED visits within 
the 14 emergency departments operated by Kaiser Permanente Southern California. The study 
included all ED visits from 2008 to 2013 for members older than 50 years who received a D-
dimer test. To ensure every PE diagnosis was captured, claims for care outside the system within 
the given time period were included as well. Only patients with membership continuing 30 days 
after the encounter were included in this study.   
This study aimed to focus on those with a suspected pulmonary embolism, not deep vein 
thrombosis, therefore, only patients with a chief complaint related to possible pulmonary 
embolism, such as chest pain or dyspnea, were included. Those who underwent ultrasonographic 
imaging evaluation for deep vein thrombosis were also excluded. To ensure that only initial 
evaluations for pulmonary embolism were included, those with a pulmonary embolism diagnosis 
in the previous 30 days were also excluded. In the analysis of the data, patients with 
thrombophilia and cancer were identified due to their increased risk of pulmonary embolism.   
The primary outcome of this study was an encounter diagnosis of acute PE. The 
individualized D-dimer was calculated by multiplying the patient’s age in year by ten. 
Additionally, the current D-dimer cutoff (500 ng/dL) and a higher fixed cutoff (1000 ng/dL) 
were used in calculations to compare sensitivity, specificity, positive and negative predictive 
values.   
Patients receiving CT pulmonary angiography (CTPA), ventilation-perfusion scan, 
pulmonary angiography, or chest magnetic resonance angiography were identified and used to 
describe the proportion of ED patients receiving advanced imaging within 24 hours after their 
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arrival. The data was also stratified by patients receiving imaging who had a D-dimer below the 
standard cutoff and patients who did not receive imaging despite a D-dimer above the cutoff. 
Missed PEs were identified by reporting patients who neither received a diagnosis of PE nor 
received imaging to identify PE at the time of the ED encounter, but received a diagnosis of PE 
within 30 days of the initial encounter. These charts were then reviewed to determine whether 
the PE was present and missed at the initial ED visit or if it developed within 30 days after the 
visit. 
To estimate the number of cases of contrast-induced nephropathy (CIN), episodes of 
severe renal failure, and deaths related to contrast-induced nephropathy, this study used 
previously  published prospective findings to compare with their results. They identified patients 
with acute kidney injury and unspecified kidney failure within 30 days of the ED visit and 
further separated these results into those who received imaging and those who did not. These 
results were used to estimate the number of patients who would receive imaging according to 
different thresholds and determine their risk of imaging-related complications. 
 
Results  
This study found that the age-adjusted D-dimer was 92.9% sensitive and 63.9% specific 
with a positive predictive value of 4.1% and a negative predictive value of 99.8% for detecting 
PE. The standard cutoff was 98.0% sensitive and 54.4% specific with a positive predictive value 
of 3.4% and a negative predictive value of 99.9% for detecting PE. The higher fixed cutoff of 
1000 ng/dL was 84.2% sensitive and 75.4% specific with a positive predictive value of 5.4% and 
a negative predictive value of 99.7% in the detection of PE. 
In total, 12,486 patients (40.2%) received imaging in which 87% were CT pulmonary 
angiography, 10.5% were pulmonary perfusion scans, and 2.5% were chest CTs with contrast. Of 
those who received imaging, 1,323 (10.6%) had a D-dimer below the conventional threshold of 
500 ng/dL, in which one third of these imaging procedures were documented as procedures to 
rule out other possible causes, such as aortic dissection. Five patients were identified with missed 
pulmonary embolisms (2.3%) that were detected within 30 days, all of whom had a D-dimer 
result above the age-adjusted cutoff.   
During the 6-year study period, the expected number of missed PE diagnoses due to false 
negative D-dimer results would have been 36 with the age-adjusted threshold, 10 with the 
conventional threshold (500 ng/dL), and 80 with a threshold of 1,000 ng/dL. Although the 
application of an age-adjusted D-dimer would cause misdiagnosis of 26 more PEs than the 
conventional cut-off, it would also prevent 322 cases of CIN, 29 cases of severe renal failure, 
and 19 deaths related to CIN in this study.  The results of each imaging-related outcome were 
used to estimate the number of each event per 10,000 suspected pulmonary embolism 
encounters, as seen in Table 2. 
 
Table 2. Estimated clinical consequences of different D-dimer thresholds 
D-dimer 
threshold 
Cases of Contrast-Induced 
Nephropathy 
Severe Renal Failure Deaths Related to CIN 
500 ng/dL 511 44 29 
1000 ng/dL 283 24 16 
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Age-
adjusted 
409 35 23 
 
 
Study 3: 
Age Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE study. 
Righini et al.6 
 
Objective  
This study examined the efficacy of using age-adjusted D-dimer levels in elderly patients 
with a suspected PE.  
 
Study Design  
This was a prospective cohort study including 3,324 patients presenting with symptoms 
of PE in emergency departments in Belgium, France, the Netherlands, and Switzerland between 
January 1, 2010 and February 28, 2013. Consecutive patients with PE symptoms and a non-high 
clinical probability based on the revised Geneva score or the Wells criteria underwent D-dimer 
testing. Patients whose D-dimer levels were below the conventional cutoff of 500 µg/L or 
between the conventional cutoff and their age-adjusted D-dimer were followed up for three 
months. Patients with a D-dimer higher than their age-adjusted cutoff, or those found to be at 
high risk of PE as determined by the aforementioned scoring systems, underwent CTPA and 
were considered for anticoagulant therapy depending on the results. Patients excluded from the 
study were patients in whom symptoms of a PE occurred more than 24 hours after being in the 
hospital, those on anticoagulation therapy, those with an allergy to contrast medium, impaired 
renal function, life expectancy of less than three months, ongoing pregnancy, or inaccessibility 
for follow-up.  
Patients were divided into three groups depending on the outcome of their D-dimer 
results and statistical probability of PE. A fourth group was made focusing specifically on the 
efficacy of age-adjusted D-dimer in elderly patients, defined as those over the age of 75. 817 
patients had a low probability and a D-dimer less than 500 µg/L. 337 patients had a low 
probability and a D-dimer above 500 µg/L but below their age-adjusted cutoff. The remaining 
1,744 patients with a low probability had an elevated D-dimer according to both methods, and 
were grouped with the 426 patients who had a high clinical probability for further testing. There 
was a total of 766 elderly patients; 673 of those were considered to have a non-high clinical 
probability and were categorized to further examine the utility of the age-adjusted D-dimer in 
this age population. Each group underwent follow-up at three months. Several participants were 
lost to follow-up or placed on anticoagulants for other reasons and were therefore excluded from 
the study at that time. 
Failure rate of the age-adjusted D-dimer cutoff was the primary outcome measured. It 
was determined by the number of thromboembolic events that occurred in the three-month 
follow-up period among patients with an initial negative D-dimer according to their age-adjusted 
cutoff. Events were assessed by three independent experts that were blinded to the D-dimer 
levels. Deaths were judged to be surely related, probably related, possibly related, or unrelated to 
PE. Sample sizes were determined by a previous retrospective study done by the authors and 
general characteristics of each patient were categorized. Means and standard deviations or 
medians and interquartile ranges were calculated for all continuous variables. Proportions were 
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used for categorical variable and the Wilson score method was used to determine a 95% 
confidence interval (CI).  
 
Results  
At three-month follow-up, those with a D-dimer less than 500 µg/L had a 
thromboembolic risk of 1 in 810 patients (0.1%). Risk for using the age-adjusted cutoff was 
found to be 1 in 331 patients (0.3%). Those with a high clinical probability or a high D-dimer 
underwent CTPA and other testing if necessary. 631 patients had a confirmed PE. The remaining 
1,539 patients were followed for three months. Their risk was found to be 7 in 1,481 patients 
(0.5%). There was a total of 766 patients 75 years of age and older, with 673 of those having a 
non-high clinical probability. 43 of those patients had a D-dimer less than 500 µg/L and 157 had 
a D-dimer below their age-adjusted cutoff, totaling 200 patients. Five of those patients were lost 
to follow-up. In the remaining 195, there was no occurrence of VTE at three-month follow-up. 
Results are shown in Table 3. 
 
Table 3. PE events during three-month follow-up categorized by clinical probability and D-
dimer concentration  
 D dimer 
<500 
µg/L 
D dimer >500 
but < age 
adjusted cutoff 
D dimer > age adjusted 
cutoff or patient with 
high probability 
Elderly patients 
(>75 years old) 
with non-high 
probability 
Total number 
of patients 
817 337 1,539 673 
Patients lost to 
follow-up 
7 6 58 5 
Patients with 
PE during 
follow-up 
1 1 7 0 
 
2x2 tables were created by the authors of this study to further analyze the results, as seen in 
tables 4 and 5. Sensitivity was the same, at 99.9%, for both the conventional and age-adjusted 
cutoff. Specificity was 30.8% for the conventional cutoff, but rose to 43.5% using age-adjusted 
values. For both cutoffs, negative predictive value was found to be 99.9%. The conventional 
cutoff resulted in a positive predictive value of 25.9%, while the age-adjusted cutoff resulted in a 
positive predictive value of 29.9%.  
 
Table 4. 2x2 for the age-adjusted cutoff  Table 5. 2x2 for the conventional cutoff 
 VTE No VTE 
+D-dimer 632 1811 
-D-dimer 1 809 
 
 VTE No VTE 
+D-dimer 631 1481 
-D-dimer 2 1139 
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Discussion 
 
The data from this review concludes that an age-adjusted cutoff value for D-dimer 
increases the specificity of the D-dimer test without compromising sensitivity, therefore, 
improving the clinical utility of the test and reducing unnecessary imaging in patients >50 years.  
These results were consistent throughout the studies, as seen in Table 6. However, limitations 
exist in the analysis of this data, and further research is warranted before the implementation of 
these recommendations in ED management of patients with suspected VTE.   
 
Table 6. Overview of Results 
 Sensitivity Specificity Positive Predictive Value Negative Predictive Value 
 Conventional 
Cutoff (%) 
Age-
Adjusted 
Cutoff (%) 
Conventional 
Cutoff (%) 
Age-
Adjusted 
Cutoff (%) 
Conventional 
Cutoff (%) 
Age-
Adjusted 
Cutoff (%) 
Conventional 
Cutoff (%) 
Age-
Adjusted 
Cutoff (%) 
Study 
1 
99.3% 97.8% 36.1% 48.8% N/A N/A N/A N/A 
Study 
2 
98.0% 92.9% 54.4% 63.9% 3.4% 4.1% 99.9% 99.8% 
Study 
3 
99.9% 99.9% 30.8% 43.5% 25.9% 29.9% 99.9% 99.9% 
 
 Study 1 was a meta-analysis including five cohort studies with a total of 12,497 patients, 
a large enough study size to adequately represent the population. All of the studies chosen in this 
review had a significant degree of similarity in selecting patients, focusing only on patients with 
a non-high clinical probability. Other strengths of this study include the stratification of data into 
predefined age groups and D-dimer cutoff values and the use of reference testing to further 
support the D-dimer outcome.  
A potential limitation of this study is that the included publications came from only three 
research groups. While this introduces the potential for publication bias from the sources, the 
authors of this meta-analysis state that funnel plots estimating effect size against study size gave 
no indication for bias, and that adding more studies would not have significantly altered the 
results. Study selection was also decreased due to the use of other methods to adjust the D-dimer 
cutoff values. It has also been suggested that a fixed cut-off of 750 µg/L be used in patients >60 
or >70 years. Due to differences in the sensitivity and specificity of D-dimer assays, different 
methods, and lack of categorization of age groups, any studies with a fixed cutoff had to be 
excluded. The authors do note a degree of heterogeneity in the sensitivity and specificity of the 
D-dimer tests among the studies due to the use of different assays. Previous studies have shown 
that enzyme linked fluorescent assays have a higher sensitivity and lower specificity than second 
generation latex assays. The authors were not able to control for this variation in the research; 
therefore, they could not determine the differences between the two assays.  
Lastly, reference standards used to confirm or exclude VTE differed among publications. 
12 of the 13 studies used a three-month event-free follow-up instead of imaging to confirm the 
absence of VTE. This could lead to a degree of bias due to differences in verification. It could 
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have also overestimated the diagnostic accuracy of the age-adjusted D-dimer, considering a 
small thrombus may be missed in these patients.  
Study 2 was a retrospective cohort study with positive aspects, including a sample size of 
31,094 patients taken from a diverse population. All tests and evaluations were performed by 
fully trained physicians, and data were extracted by trained research staff experienced in analysis 
of Kaiser Permanente’s data.   
The lack of prospective data is an obvious limitation of this study. Other limitations of 
this study include evaluation and spectrum biases, causing differing results due to the application 
of any threshold to different samples, as well as inconsistency in interpretation of imaging. In 
addition, the review of missed PEs was conducted by the research team, who were not blinded to 
the eventual PE diagnosis, which may be a source of bias. This study also does not evaluate 
using a common decision-making tool such as Wells or PE rule-out criteria.  However, the 
authors of this study found that a significant number of patients receive diagnostic testing, 
despite the use of current decision-making tools and recommendations. 
Strengths of study 3 include its large, international sample size and the use of a blinded, 
independent committee to determine the cause of all suspected thromboembolic events or deaths 
in the follow-up period and their relation to the study. Limitations include the use of multiple D-
dimer assays, which have been shown in prior studies to have differing sensitivities and 
specificities. Unlike the first study, however, results between the assays were homogenous. 
Another limitation is the study type. Had this study been a randomized control trial, researchers 
would have had a control group that used the conventional cutoff for diagnosis to compare to. 
Lastly, only one of the seven deaths in the patients with a D-dimer below the age-adjusted cutoff 
had an autopsy, the most definitive method to exclude PE. While the deaths were reviewed and 
ruled upon by a blinded committee, PE cannot technically be formally excluded.  
When viewing these studies as a whole, limitations arise in the selection of patients, as 
two studies used the Wells criteria and revised Geneva score to determine a patient’s clinical 
probability of having a VTE, while the second article used clinical symptoms to determine 
likelihood. This may have altered the categorization of the patients and overall application of the 
results to a patient population.   
Another shortcoming of this review is the varying prevalence of VTE within the study 
population. Study 2 had an overall prevalence of PE of 19% in the study population, while study 
3 had an overall prevalence of 1.69%. Study 1 had a prevalence of VTE ranging from 12.3% in 
patients aged less than 50 years to 21.5% in patients aged 71-80. Considering that the main 
outcome of this review is the ability of D-dimer cutoffs to correctly identify VTE, the variation 
in prevalence among the studies may contribute to differing rates of detection. Finally, variations 
in follow-up contribute to the limitations of this review. Study 3 and many of the studies 
included in the meta-analysis (study 1) used a three-month follow-up, while the remaining 
studies used a 30-day follow-up. Those who were followed only after 30 days could have 
developed a VTE in the next two months, and these occurrences would not have been recorded. 
In addition to these limitations, it must be considered that the studies included in this 
review took place in various settings and locations, including hospital outpatients, inpatients, and 
primary care facilities from Southern California, Belgium, France, and Switzerland among other 
locations.  While this could be viewed as a source of variation among studies and considered a 
limitation, it could also be viewed as a positive aspect of this review, as it allows the results to be 
generalized to a large population of patients.  Results were relatively consistent throughout the 
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studies, further confirming that an age-adjusted D-dimer threshold could be implemented in 
various settings across medicine. 
Other strengths of this review include the large patient population, as seen in Table 7, 
with similar patient demographics and selection criteria. In addition, study design of each of the 
studies varied slightly, but focused on the same overall outcomes and resulted in the same 
general conclusions. This review also included three different types of studies, adding to the 
significance of the results and further suggesting that an age-adjusted D-dimer threshold can 
improve clinical utility of the D-dimer test. 
 
 
Table 7. Overview of Studies 
 Schouten et al.2 Sharp et al.5 Righini et al.6 
Patients, N 12,497 31,094 3,346 
Patient 
population 
Patients >50 years with 
suspected VTE 
Patients >50 years with 
suspected PE 
Patients >50 years with 
clinically suspected acute 
PE 
Study Type Meta-analysis Retrospective study Prospective diagnostic 
management outcome 
study 
Clinical tool used 
to determine 
possible VTE 
PE: Revised Geneva 
score of <10 or a Wells 
score of <4 
DVT: Wells score of 
either <2 or <1 
Patients presenting with 
a chief complaint related 
to PE such as chest pain 
or dyspnea 
Simplified, revised Geneva 
score or 2-level Wells 
score for PE 
Follow-up period 12 studies: 3 months 
One study: 45 days 
30 days 3 months 
Patient 
Characteristics 
Mean age: 60 yo 
Women: N/A 
Men: N/A 
Mean age: 65 yo 
Women: 61% 
Men: 39% 
Median age: 63 yo 
Women: 56.8% 
Men: 43.2% 
Conclusion Age-adjusted cutoff 
values for D-dimer 
tests increases 
specificity, without 
reducing sensitivity, 
thereby improving 
clinical utility. 
An age-adjusted D-
dimer limit is more 
accurate than a standard 
threshold to reduce 
imaging among older 
ED patients. 
Compared with a fixed D-
dimer cutoff, age-adjusted 
D-dimer cutoff was 
associated with a larger 
number of patients in 
which VTE can be ruled 
out. 
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Clinical Application 
 
 Mr. RD is a 67-year-old male with no significant medical history who presents to the 
clinic complaining of right lower extremity swelling. His D-dimer value is 640 µg/L. This is a 
positive D-dimer result according to the conventional cutoff (500 µg/L), meaning he would 
undergo further testing and potentially be placed on anticoagulants. However, his age-adjusted 
D-dimer cutoff is 670 µg/dL (age x 10), therefore, he would not qualify for further evaluation.  
According to the Wells criteria for DVT, he is at moderate risk for DVT, with a pre-test 
probability of 17%. This pre-test probability was applied to two nomograms, Figures 2 and 3, 
along with positive and negative likelihood ratios to determine the post-test probability of Mr. 
RD having a DVT.  Figure 2 illustrates the negative post-test probability, meaning that if Mr. RD 
had a negative age-adjusted D-dimer, he would have less than a 2% chance of having a DVT 
based on these three studies.  Figure 3 illustrates the positive post-test probability, meaning that 
if Mr. RD had a positive test, he would have a 15-30% chance of having a DVT based on these 
three studies and would most likely undergo further testing. 
 
   
Figures 2 and 3. Nomograms with negative and positive likelihood ratios 
 
 
 
Conclusion 
 
D-dimer is a commonly used test for excluding VTE in patients with a non-high clinical 
probability. However, its use is limited in older patients (>50 years old) due to its decreasing 
specificity with increasing age, resulting in unnecessary testing and increased burden on these 
patients. Use of an age-adjusted D-dimer increases the number of patients in which VTE can be 
excluded without imaging. In addition to increasing specificity, sensitivity remained high among 
all studies. This study further supports the use of an age-adjusted D-dimer cutoff in patients >50 
Key:
Study 1: lilac
Study 2: plum
Study 3: gray
 14 
years old. Future studies that would be beneficial include a randomized control trial comparing 
the two cutoffs and examination of cost effectiveness and implementation into practice. The use 
of different D-dimer assays should also be addressed. Currently, studies are inconclusive as to 
whether different D-dimer assays affect the utility of the age-adjusted cutoff. 
 
Acknowledgements 
The authors would like to thank Dr. Erika Kancler and Carolyn Schubert for their 
guidance on this project.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15 
 
 
 
 
 
References 
 
1. Pulivarthi S, Gurram MK. Effectiveness of D-Dimer as a Screening Test for Venous 
Thromboembolism: An Update. North American Journal of Medical Sciences. 2014;6(10):491-
499. doi:10.4103/1947-2714.143278. 
2. Schouten HJ, Geersing GJ, Koek HL, et al. Diagnostic accuracy of conventional or age 
adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: 
systematic review and meta-analysis. British Medical Journal. May 2013. 
doi:10.1136/bmj.f2492. 
3. Zehnder JL. Clinical use of coagulation tests. Clinical use of coagulation tests. 
http://www.uptodate.com/contents/clinical-use-of-coagulation-tests. Published June 6, 2016. 
Accessed November 23, 2016. 
4. Woller SC, Stevens SM, Adams DM, et al. Assessment of the safety and efficiency of using an 
age-adjusted D-dimer threshold to exclude suspected pulmonary embolism. Chest. 
2014;146(6):1444-1451. 
5. Sharp AL, Vinson DR, Alamshaw F, Handler J, Gould MK. An Age-Adjusted D-dimer 
Threshold for Emergency Department Patients With Suspected Pulmonary Embolus: Accuracy 
and Clinical Implications. Annals of Emergency Medicine. 2016;67(2):249-257. 
doi:10.1016/j.annemergmed.2015.07.026. 
6. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out 
pulmonary embolism: The ADJUST-PE study. JAMA. 2014;311(11):1117-1124. 
7. Lo BM. Deep Venous Thrombosis Risk Stratification. Medscape. 
http://emedicine.medscape.com/article/1918446-overview. Published October 13, 2016. 
Accessed November 27, 2016. 
 
 
